A comprehensive overview of potential stem cell applications across diverse medical fields, based on clinical trials and research.
Compared to adult bone marrow, stem cells derived from umbilical cord blood offer distinct biological advantages that translate to better clinical outcomes.
UCB cells are less likely to trigger immune rejection, making them safer for allogeneic transplants.
UC-MSCs produce cytokines that actively facilitate grafting and enhance in vitro survival rates compared to bone marrow MSCs.